Sun Pharma Q4 net profit rises 26.2% to ₹27,140 million
after close1 source ↓written by the desknot a recommendation
- YoY for Q4
- 26.2%
- Consolidated sales reached
- ₹145,598 million
- growth
- 13.6%
- Medicines sales increased
- 20.1%
Sun Pharmaceutical reported net profit of ₹27,140 million, up 26.2% YoY for Q4 FY26. Consolidated sales reached ₹145,598 million, reflecting a 13.6% growth. Global Innovative Medicines sales increased 20.1% to USD 354 million, contributing 22.2% to overall sales. This performance may enhance investor sentiment in the pharmaceutical sector.
Not investment advice. For informational purposes only.